BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 25, 2009
View Archived Issues
Inovio Biomedical reports on preclinical studies of universal influenza vaccine
Read More
Sanofi-Aventis reports results from third quarter of 2009
Read More
TAK-901 has potent antitumor activity in xenograft mouse models of human malignancies
Read More
Roche initiates enrollment of cohort 2 in phase IIb trial of RG-7128 in HCV
Read More
AMG-900 exhibits potent activity against multidrug-resistant tumors in preclinical studies
Read More
Vical completes final patient follow-up visit of phase II TransVax trial in HCT recipients
Read More
Cytheris starts NCI/NIH-sponsored phase I/IIa trial of CYT-107 to enhance tumor vaccination
Read More
NIH awards grant to RPCI for study of tamoxifen in breast cancer
Read More
Clavis and Clovis sign development and commercialization agreement for CP-4126
Read More
FDA grants fast track designation to ARCA biopharma's Gencaro in heart failure
Read More
Galapagos initiates phase II clinical study of Nanocort for flares in MS
Read More
Addex reports preclinical data on ADX-48621 for Parkinson's disease
Read More
Novartis receives approval in Switzerland for Celtura pandemic influenza vaccine
Read More
Sinovac Biotech's Panflu.1 H1N1 vaccine approved for geriatric population in China
Read More
MenACWY-TT vaccine elicits a persistent immune response in adolescents
Read More
Non-adjuvanted H5N1 vaccine containing HA is safe and immunogenic in children
Read More
Millennium initiates phase I clinical trial of proteasome inhibitor MLN-9708
Read More
Ception Therapeutics and Cephalon provide results of phase IIb/III Cinquil trial
Read More
JUPITER data shows that rosuvastatin reduces risk of cardiovascular events
Read More
ADX-10059 is safe and effective in healthy subjects; evaluation in GERD anticipated
Read More
Shire submits MAA to EMEA for velaglucerase alfa for type 1 Gaucher disease
Read More
Palau Pharma discloses H4 receptor antagonists for the treatment of pain
Read More
Scancell to initiate a phase I/II trial of DNA ImmunoBody vaccine SCIB1 for melanoma
Read More
Gilead identifies SCD inhibitors for the treatment of diabetes
Read More
Caspase inhibitors disclosed by LG Life Sciences for acute hepatitis therapy
Read More
IRM and Novartis present ALK kinase inhibitors for cancer treatment
Read More
Novel 5-HT6 receptor antagonists disclosed by Solvay as anxiolytics
Read More